Skip to main content

Octagon Capital Advisors LP

Position in DNTH — Dianthus Therapeutics, Inc. /DE/

CIK 1839435 NEW YORK, NY

Position in DNTH

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$163,364,294
+$63,773,447 QoQ
Shares Held
1,946,667
-19.4% QoQ
Ownership
3.56%
of shares outstanding
% of Portfolio
18.08%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2023
11 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in DNTH Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Octagon Capital Advisors LP holds $869,736,107 across 27 Biotechnology names. DNTH ranks #1 (18.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 DNTH
Dianthus Therapeutics, Inc. /DE/
This page
1,946,667 $163,364,294

All Filings in DNTH

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $163,364,294 1,946,667
2025-12-31 $99,590,847 2,416,667
2025-09-30 $95,095,846 2,416,667
2025-06-30 $43,625,256 2,341,667
2025-03-31 $42,477,839 2,341,667
2024-12-31 $46,001,640 2,110,167
2024-12-31 $46,001,640 2,110,167
2024-09-30 $47,823,742 1,746,667
2024-06-30 $45,203,741 1,746,667
2024-03-31 $41,420,010 1,380,667
2023-12-31 $5,761,600 554,000
2023-09-30 $6,561,600 480,000